0
     

Report Added
Report already added
Global Clinical Communication and Collaboration Market 2022-2028

Global Clinical Communication and Collaboration Market 2022-2028

Clinical communication and collaboration (CC&C) systems coordinate activities and data flow between clinicians, nurses, physicians, and other medical professionals. Hospitals, ancillary care providers, and clinical laboratories can leverage CC&C solutions to reduce referral leakage and rate of readmissions, and ensure interoperability between systems. With a CC&C platform deployed, health care organizations and practices can maintain patient data, facilitate real-time collaboration, reduce inefficiency and gaps, achieve patient safety and satisfaction, and preserve profitability. According to market research study published by Gen Consulting Company, the global clinical communication and collaboration market stood at around USD 1,451 million in 2021 and is projected to rise to a worth of USD 3,499 million by 2028 end, thereby garnering a CAGR of 13.4% during 2022-2028.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global clinical communication and collaboration market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the clinical communication and collaboration industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the component, deployment, end user, and region. The global market for clinical communication and collaboration can be segmented by component: solution, services. The solution segment held the largest revenue share in 2021. Clinical communication and collaboration market is further segmented by deployment: cloud-based, on-premise. Based on end user, the clinical communication and collaboration market is segmented into: clinical labs, hospitals, physicians, others. On the basis of region, the clinical communication and collaboration market also can be divided into: North America, Asia Pacific, Europe, Rest of the World (ROW).

By component:
- solution
- services

By deployment:
- cloud-based
- on-premise

By end user:
- clinical labs
- hospitals
- physicians
- others

By region:
- North America
- Asia Pacific
- Europe
- Rest of the World (ROW)

The report has also analysed the competitive landscape of the global clinical communication and collaboration market with some of the key players being AGNITY Inc., Avaya Holdings Corp., Cerner Corporation, Cisco Systems, Inc., d/b/a symplr, Everbridge, Inc., Hill-Rom Holdings, Inc., Intel Corporation, Jive Software, Inc., Microsoft Corporation, NEC Corporation, Plantronics, Inc., Spok Inc., Stryker Corporation, UDG Healthcare plc, Uniphy Health Holding LLC, Vocera Communications, Inc., among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report
- To analyze and forecast the market size of the global clinical communication and collaboration market.
- To classify and forecast the global clinical communication and collaboration market based on component, deployment, end user, region.
- To identify drivers and challenges for the global clinical communication and collaboration market.
- To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global clinical communication and collaboration market.
- To identify and analyze the profile of leading players operating in the global clinical communication and collaboration market.

Why Choose This Report
- Gain a reliable outlook of the global clinical communication and collaboration market forecasts from 2022 to 2028 across scenarios.
- Identify growth segments for investment.
- Stay ahead of competitors through company profiles and market data.
- The market estimate for ease of analysis across scenarios in Excel format.
- Strategy consulting and research support for three months.
- Print authentication provided for the single-user license.
TABLE OF CONTENTS

FIGURES AND TABLES
PART 1. INTRODUCTION
· Report description
· Objectives of the study
· Market segment
· Years considered for the report
· Currency
· Key target audience
PART 2. METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
· Introduction
· Drivers
· Restraints
· Impact of COVID-19 pandemic
PART 5. MARKET BREAKDOWN BY COMPONENT
· Solution
· Services
PART 6. MARKET BREAKDOWN BY DEPLOYMENT
· Cloud-based
· On-premise
PART 7. MARKET BREAKDOWN BY END USER
· Clinical labs
· Hospitals
· Physicians
· Others
PART 8. MARKET BREAKDOWN BY REGION
· North America
· Asia Pacific
· Europe
· Rest of the World (ROW)
PART 9. KEY COMPANIES
· AGNITY Inc.
· Avaya Holdings Corp.
· Cerner Corporation
· Cisco Systems, Inc.
· d/b/a symplr
· Everbridge, Inc.
· Hill-Rom Holdings, Inc.
· Intel Corporation
· Jive Software, Inc.
· Microsoft Corporation
· NEC Corporation
· Plantronics, Inc.
· Spok Inc.
· Stryker Corporation
· UDG Healthcare plc
· Uniphy Health Holding LLC
· Vocera Communications, Inc.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER

Report Title: Global Clinical Communication and Collaboration Market 2022-2028


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

China Bispecific Antibody Market Opportunity & Clinical Trials Insight 2028

China Bispecific Antibody Market Opportunity & Clinical Trials Insight 2028

2022 Vietnam Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Vietnam Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Venezuela Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Venezuela Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Uruguay Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Uruguay Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 United Arab Emirates Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 United Arab Emirates Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Ukraine Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Ukraine Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline